Research Community
GP2's Research Community
GP2 is a product and a source of collaboration. The individuals and groups that contribute to GP2 drive its strategy, its operations, and ultimately its impact. Read more.
Training
Training
At GP2, we are committed to creating a global research community with the tools and infrastructure to address emerging research needs and questions. Read more.
Data Resources
Data Resources
GP2 develops and maintains tools that assemble clinical and genetic data to help accelerate research across the Parkinson’s Disease Research community. Read more.

Anne-Marie Wills, MD

Harvard Medical School

Boston, MA, USA

Working Group

Member, Monogenic Network

Area of Focus

Progressive supranuclear palsy (PSP)
Multiple System Atrophy
Atypical Parkinson's

Biography

Dr. Wills is the Director of the CurePSP Center of Care at Massachusetts General Hospital. She has clinical expertise in Movement Disorders including PSP, DLB and PD, formal training in clinical trial design and implementation, and experience designing innovative clinical trials using remote data collection. She is the co-PI of the multicenter Progressive Supranuclear Palsy Clinical Trial Platform (PTP) (R01 AG085029) and the PI of the CurePSP Genetics Program.